Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice
Year: 2009
Type: article
Source: Experimental Neurology
Institution: University of California San Diego
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
Awards: Gene Therapy for Alzheimer's Disease, a-synuclein clearance strategies for the treatment of Lewy body disease, G2937085932, a-Synuclein vulnerability mechanisms and therapeutics in Alzheimer's Disease, UCSD Alzheimer's Disease Research Center P50, G3457996028, La Jolla Interdisciplinary Neuroscience Center Cores, G486772123, Proteinopathies of the Aging Central Nervous System, G9000035899
OpenAlex ID: W1991157941
